Home / Companies / Pliant Therapeutics, Inc. / 13 Jun 2024
Pliant Therapeutics, Inc.: meeting of 13 Jun 2024
Votes reported on Form N-PX, item by item
245 Form N-PX filers reported votes at the Pliant Therapeutics, Inc. meeting of 13 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 74.5% of reported votes for; 47 filers withheld from or voted against at least one nominee.
468 vote records from 88 filers. 4 of the 87 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
356 vote records from 245 filers. 182 of the 234 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
156 vote records from 88 filers. 0 of the 87 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | For | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | For | Against * | For |
| Equitable | Abstain or withhold * | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | For | Against * | For |
| Goldman Sachs | No report | Against * | No report |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | For | Against * | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | For | Against * | For |
| Russell Investments | For | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | No report | Against * | No report |
| Principal | For | Against * | For |
| Capital Group and American Funds | For | Against * | For |
| Pacific Life funds | For | Against * | For |
| Global X | For | Against * | For |
| Transamerica | For | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | For | Against * | For |
| MassMutual | Split or no vote | Split or no vote | Split or no vote |
| Harbor Funds | For | For | For |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Pliant Therapeutics, Inc. meeting?
245 Form N-PX filers reported votes at the meeting of 13 Jun 2024. On say-on-pay, 182 of 234 voted against management (77.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Pliant Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Pliant Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Pliant Therapeutics, Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.